Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure ...
An ad-hoc analysis found a higher rate of severe and life-threatening infections in patients with RET-mutant lung cancer ...
The FDA extended the Prescription Drug User Fee Act date for the biologics license application seeking approval of ...
The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.
Surveyed individuals who identified as a racial or ethnic minority reported difficulties discussing cancer diagnosis and treatment. Typical stories shared about “going flat” after a mastectomy may not ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback